MUC21: a new target for tumor treatment.

导出 LinkOut

翻译打印收藏纠错

第一作者： Miao,Li

第一单位： Jishou University Zhuzhou Clinical College, Medical College, Jishou University, Zhuzhou, Hunan, China.

作者： Miao,Li ^[1] ; Hui,Li ^[2] ; Ting,Yuan ^[2] ; Zhi,Liu ^[3] ; Yukun,Li ^[3] ; Yingzheng,Tan ^[4] ; Yunzhu,Long ^[1]

作者单位： Jishou University Zhuzhou Clinical College, Medical College, Jishou University, Zhuzhou, Hunan, China. ^[1] Medical College, Jishou University, Jishou, Xiangxi Tujia and Miao Autonomous Prefecture, Hunan, China. ^[2] Department of Infectious Disease, Zhuzhou Central Hospital, Xiangya Hospital Zhuzhou Central South University, Central South University, Zhuzhou, Hunan, China. ^[3] Department of Assisted Reproductive Centre, Zhuzhou Central Hospital, Xiangya Hospital Zhuzhou Central South University, Central South University, Zhuzhou, Hunan, China. ^[4]

关键词 MUC21 biomarkers cancer immune infiltration infection

DOI 10.3389/fonc.2024.1410761

PMID 38933439

发布时间 2024-06-28

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Frontiers in oncology

2024年14卷

1410761页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

MUC21: a new target for tumor treatment.

Frontiers in oncology

相似文献

Frontiers in oncology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

MUC21: a new target for tumor treatment.

Frontiers in oncology

相似文献

Frontiers in oncology

相关期刊

检索历史清除